2015
Chapter 49 Antioxidant Status in Vascular Dementia
Zito G, Squitti R, Polimanti R. Chapter 49 Antioxidant Status in Vascular Dementia. 2015, 529-537. DOI: 10.1016/b978-0-12-407824-6.00049-5.Peer-Reviewed Original ResearchVascular dementiaSystemic oxidative stress markersAdministration of antioxidantsOxidative stress markersVaD patientsPathological featuresSupplementation therapyAntioxidant statusStress markersCognitive declineOxidative stressEffectiveness of antioxidantsDementiaVADCommon formClinical experimentsPatientsAntioxidantsDifferent studiesPathogenesisTherapyAdministrationCaregivers
2013
Antioxidant Status and APOE Genotype As Susceptibility Factors for Neurodegeneration in Alzheimer's Disease and Vascular Dementia
Zito G, Polimanti R, Panetta V, Ventriglia M, Salustri C, Siotto MC, Moffa F, Altamura C, Vernieri F, Lupoi D, Cassetta E, Rossini PM, Squitti R. Antioxidant Status and APOE Genotype As Susceptibility Factors for Neurodegeneration in Alzheimer's Disease and Vascular Dementia. Rejuvenation Research 2013, 16: 51-56. PMID: 23216585, PMCID: PMC3582293, DOI: 10.1089/rej.2012.1383.Peer-Reviewed Original ResearchConceptsAntioxidant statusΕ4 alleleVascular dementiaHealthy controlsSerum total antioxidant statusOxidative stressHigher WMH scoresTotal antioxidant statusWhite matter hyperintensitiesAPOE ε4 alleleElderly healthy controlsWMH scoresVaD patientsAtrophy assessmentLipid dyshomeostasisNeurodegenerative processesMatter hyperintensitiesPathogenetic pathwaysApolipoprotein EAlzheimer typeSystem homeostasisAlzheimer's diseaseTAS concentrationDisease riskLipid metabolism